🇺🇸 TANDEM DIABETES CARE INCTNDM

Company Update Form 8-K 13-11-2026 08:35:29 EST

Subject: 8-K Items 8.01

Overview: Received FDA 510(k) clearance for Tandem Mobi tubeless cartridge and infusion set, with a planned U.S. commercial launch in the first half of 2027.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest